At the recent 8th AORTIC Conference, held in Cairo on Nov 30th-trough Dec 02, Dr Mbulaiteye explained during an interview to ecancer.tv the articulation and the relevance of the EMBLEM study, which is focused on revisiting the etiopathogenesis of Burkitt’s lymphoma 50 years following the first studies.
Franco Buonaguro
Dr Buonaguro is the Editor-in-Chief of Infectious Agents and Cancer. He is currently the Director of Molecular Biology and Viral Oncology Unit, in the Department of Experimental Oncology at the Natl Cancer Institute “Fondazione Pascale”, Naples - Italy.
Latest posts by Franco Buonaguro (see all)
- Red de Institutos Nacionales de Cancer de Latinoamérica RINC-ALC - 26th June 2019
- Pioneers in Infectious Agents and Cancer Meeting - 2nd March 2017
- IARC 50th Anniversary Meeting 2016 - 13th June 2016
Nature Precedings ceased accepting new
submissions as of April 3rd, 2012, https://precedings.nature.com/